Home / TBC1D14 Knockout Cell Lines

TBC1D14 Knockout Cell Lines

Gene: TBC1D14

Official Full Name: TBC1 domain family member 14provided by HGNC

Gene Summary: Enables protein kinase binding activity. Involved in negative regulation of autophagy; recycling endosome to Golgi transport; and regulation of autophagosome assembly. Located in several cellular components, including Golgi apparatus; autophagosome; and recycling endosome. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO13547 TBC1D14 Knockout cell line (HeLa) Human TBC1D14 1:3~1:6 Negative Online Inquiry
KO13548 TBC1D14 Knockout cell line (HCT 116) Human TBC1D14 1:2~1:4 Negative Online Inquiry
KO13549 TBC1D14 Knockout cell line (HEK293) Human TBC1D14 1:3~1:6 Negative Online Inquiry
KO13550 TBC1D14 Knockout cell line (A549) Human TBC1D14 1:3~1:4 Negative Online Inquiry

Background

TBC1D14 Gene Knockout Cell Lines are specialized cell lines wherein the TBC1D14 gene has been genetically disrupted, allowing for the study of the gene’s role in cellular processes such as glucose metabolism, vesicular trafficking, and insulin signaling pathways. This product provides a powerful tool for investigating the molecular mechanisms underlying various metabolic disorders, including obesity and diabetes.

The primary function of these knockout cell lines is to enable researchers to observe the effects of the absence of the TBC1D14 protein on various cellular behaviors. By leveraging CRISPR/Cas9 technology for gene editing, our TBC1D14 knockout cell lines exhibit enhanced pathways for monitoring alterations in cellular dynamics, protein interactions, and metabolic flux, providing insights into the significance of the TBC1D14 gene in live cellular systems.

From a scientific perspective, the TBC1D14 gene has gained attention for its implications in both research and therapeutic contexts. In clinical settings, understanding the function of TBC1D14 may lead to novel insights for developing interventions for metabolic diseases. These knockout cell lines facilitate high-throughput screening of potential drugs and therapeutic compounds aimed at modulating the pathways influenced by TBC1D14.

What sets our TBC1D14 Gene Knockout Cell Lines apart from similar products on the market is the precision of our gene-editing process, ensuring a complete and consistent knockout across batches. Additionally, we provide thorough characterization data, including validation of gene disruption, thus ensuring reliability for experimental reproducibility.

By employing our TBC1D14 Gene Knockout Cell Lines, researchers and clinicians gain a significant advantage in their experimental investigations due to the specificity of our models, which support targeted studies of molecular mechanisms governing crucial metabolic pathways. Our commitment to high-quality biological products reflects our expertise and dedication to advancing scientific knowledge. With extensive experience in gene editing technologies, we stand as a trusted partner in the exploration of cutting-edge biological research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.